No Data
No Data
On November 29, cspc pharma (01093) spent 29.5338 million HKD to repurchase 5.8 million shares.
cspc pharma (01093) announced that on November 29, 2024, it spent 29.5338 million Hong Kong dollars to repurchase 58...
Zhixun Hong Kong stocks repurchase statistics | November 29th
Hong Kong stock buyback statistics | November 29
cspc pharma (01093.HK) spent 29.528 million Hong Kong dollars on November 28th to repurchase 5.8 million shares.
Gelonghui November 28 │ cspc pharma (01093.HK) announced that on November 28, 2024, it invested 29.528 million Hong Kong dollars to repurchase 5.8 million shares, at a repurchase price of 5.05-5.16 Hong Kong dollars per share.
cspc pharma (01093.HK) spent 29.6071 million Hong Kong dollars on repurchasing 5.82 million shares on November 27th.
Gelonghui, November 27, cspc pharma (01093.HK) announced that on November 27, 2024, it spent 29.6071 million Hong Kong dollars to buy back 5.82 million shares, with a buyback price per share ranging from 5.02 to 5.2 Hong Kong dollars.
National medical insurance drug list unveiling soon! Keji Pharmaceutical's stock surged over 9%, leading the way in Hong Kong pharmaceutical stocks.
1. What is the importance of centralized procurement of pharmaceutical companies by medical insurance? 2. Which areas of products are expected to be included in the 2024 National Medical Insurance Drug Catalog?
Hong Kong stocks are moving differently | Most pharmaceutical stocks are rising as the results of the medical insurance negotiations are about to be revealed. Institutions indicate that the sector still has further room for recovery.
Most pharmaceutical stocks are rising, as of the deadline, Keji Pharmaceutical-B (02171) rose by 12.38%, to 7.71 Hong Kong dollars; innocare (09969) rose by 5.36%, to 6.49 Hong Kong dollars; Kainuo Ya-B (02162) rose by 4.3%, to 41.25 Hong Kong dollars.
Willis88 : Junk stocks